Back

Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Sudden cardiac death and implantable defibrillators Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Alejo Tronconi

Favaloro Foundation University Hospital, Buenos Aires (Argentina)

13 More presentations in this session

Presentation thumbnail
Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Are implantable defibrillators less useful in patients with non-ischemic heart disease?
Doctor A. Marinheiro (Setubal, PT)
Abstract
Presentation thumbnail
Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience
Miss A. Ayemon (Southampton, GB)
Abstract Slides
Presentation thumbnail
Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF
Miss A. van der Lingen (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Sudden cardiac death and implantable defibrillators

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources